Barancik Prize for Innovation in MS Research
Forecasted
The Barancik Prize for Innovation in MS Research honors exceptional, original MS research with the potential to drive new treatments or a cure, awarded by the National Multiple Sclerosis Society.
Funder: National Multiple Sclerosis Society
Due Dates (Anticipated): July 2027: Nomination deadline (projected) | September 2027: Full application deadline (projected)
Funding Amounts: $125,000 cash prize to recipient; $200,000 fellowship award at recipient’s institution for a trainee (one-time awards)
Summary: Honors an exceptional scientist or team for innovative, original research in multiple sclerosis with the goal of accelerating breakthroughs toward new treatments and a cure.
Key Information: Self-nominations are not permitted; nominees must be early to mid-career researchers with ≤20 years as independent investigator or team leader.
Description
The Barancik Prize for Innovation in MS Research is an international award administered by the National Multiple Sclerosis Society and funded by the Charles and Margery Barancik Foundation. The prize recognizes an exceptional scientist or team whose work in multiple sclerosis (MS) research demonstrates outstanding originality and innovation, with the goal of accelerating scientific breakthroughs that can lead to new treatments and, ultimately, a cure for MS. The award consists of a $125,000 cash prize for the recipient and a $200,000 fellowship at the recipient’s institution for a trainee selected by the recipient. The prize celebrates the vision of Charles and Margery Barancik, who believed that individual ingenuity can help create a world free of MS.
